Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313067189> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W4313067189 abstract "<b>Background:</b> In the SENSCIS trial in patients with SSc-ILD, nintedanib reduced the rate of decline in FVC compared with placebo. <b>Aim:</b> To assess the efficacy of nintedanib in subgroups with differing lung function impairment. <b>Methods:</b> Subjects with SSc with first non-Raynaud symptom in the prior ≤7 years, extent of fibrotic ILD ≥10%, FVC ≥40% predicted and DLco 30–89% predicted were randomised to receive nintedanib or placebo. We analysed the rate of decline in FVC (mL/year) over 52 weeks by baseline FVC <70% vs ≥70% predicted and DLco ≤50% vs >50% predicted. <b>Results:</b> At baseline, 254/575 patients (44.2%) had FVC <70% predicted and 259/568 (45.6%) had DLco ≤50% predicted. In the placebo group, the rate of decline in FVC was numerically greater in patients with FVC <70% vs ≥70% predicted and with DLco ≤50% vs >50% predicted. The effect of nintedanib vs placebo on reducing the rate of decline in FVC was numerically more pronounced in patients with FVC ≥70% vs <70% predicted and with DLco ≤50% vs >50% predicted, but exploratory interaction p-values did not indicate heterogeneity in the treatment effect between these subgroups. <b>Conclusion:</b> In the SENSCIS trial, patients with SSc-ILD with worse lung function impairment at baseline had a numerically greater rate of decline in FVC over 52 weeks. Nintedanib slowed decline in FVC irrespective of lung function impairment at baseline." @default.
- W4313067189 created "2023-01-06" @default.
- W4313067189 creator A5005411597 @default.
- W4313067189 creator A5018661508 @default.
- W4313067189 creator A5021316011 @default.
- W4313067189 creator A5046840268 @default.
- W4313067189 creator A5048431748 @default.
- W4313067189 creator A5049309150 @default.
- W4313067189 creator A5057151671 @default.
- W4313067189 creator A5091067359 @default.
- W4313067189 creator A5091359268 @default.
- W4313067189 date "2022-09-04" @default.
- W4313067189 modified "2023-09-23" @default.
- W4313067189 title "Effects of nintedanib in patients with systemic sclerosis-associated ILD (SSc-ILD) and differing levels of lung function impairment" @default.
- W4313067189 doi "https://doi.org/10.1183/13993003.congress-2022.475" @default.
- W4313067189 hasPublicationYear "2022" @default.
- W4313067189 type Work @default.
- W4313067189 citedByCount "0" @default.
- W4313067189 crossrefType "proceedings-article" @default.
- W4313067189 hasAuthorship W4313067189A5005411597 @default.
- W4313067189 hasAuthorship W4313067189A5018661508 @default.
- W4313067189 hasAuthorship W4313067189A5021316011 @default.
- W4313067189 hasAuthorship W4313067189A5046840268 @default.
- W4313067189 hasAuthorship W4313067189A5048431748 @default.
- W4313067189 hasAuthorship W4313067189A5049309150 @default.
- W4313067189 hasAuthorship W4313067189A5057151671 @default.
- W4313067189 hasAuthorship W4313067189A5091067359 @default.
- W4313067189 hasAuthorship W4313067189A5091359268 @default.
- W4313067189 hasConcept C126322002 @default.
- W4313067189 hasConcept C142724271 @default.
- W4313067189 hasConcept C16020263 @default.
- W4313067189 hasConcept C164705383 @default.
- W4313067189 hasConcept C165637977 @default.
- W4313067189 hasConcept C204787440 @default.
- W4313067189 hasConcept C27081682 @default.
- W4313067189 hasConcept C2777714996 @default.
- W4313067189 hasConcept C2778341716 @default.
- W4313067189 hasConcept C2780171596 @default.
- W4313067189 hasConcept C3018587741 @default.
- W4313067189 hasConcept C55520419 @default.
- W4313067189 hasConcept C71924100 @default.
- W4313067189 hasConcept C75603125 @default.
- W4313067189 hasConceptScore W4313067189C126322002 @default.
- W4313067189 hasConceptScore W4313067189C142724271 @default.
- W4313067189 hasConceptScore W4313067189C16020263 @default.
- W4313067189 hasConceptScore W4313067189C164705383 @default.
- W4313067189 hasConceptScore W4313067189C165637977 @default.
- W4313067189 hasConceptScore W4313067189C204787440 @default.
- W4313067189 hasConceptScore W4313067189C27081682 @default.
- W4313067189 hasConceptScore W4313067189C2777714996 @default.
- W4313067189 hasConceptScore W4313067189C2778341716 @default.
- W4313067189 hasConceptScore W4313067189C2780171596 @default.
- W4313067189 hasConceptScore W4313067189C3018587741 @default.
- W4313067189 hasConceptScore W4313067189C55520419 @default.
- W4313067189 hasConceptScore W4313067189C71924100 @default.
- W4313067189 hasConceptScore W4313067189C75603125 @default.
- W4313067189 hasLocation W43130671891 @default.
- W4313067189 hasOpenAccess W4313067189 @default.
- W4313067189 hasPrimaryLocation W43130671891 @default.
- W4313067189 hasRelatedWork W2121469082 @default.
- W4313067189 hasRelatedWork W2334210170 @default.
- W4313067189 hasRelatedWork W2462055746 @default.
- W4313067189 hasRelatedWork W2555155415 @default.
- W4313067189 hasRelatedWork W2556745572 @default.
- W4313067189 hasRelatedWork W2901235303 @default.
- W4313067189 hasRelatedWork W2906544732 @default.
- W4313067189 hasRelatedWork W2980575734 @default.
- W4313067189 hasRelatedWork W3093425191 @default.
- W4313067189 hasRelatedWork W4368358171 @default.
- W4313067189 isParatext "false" @default.
- W4313067189 isRetracted "false" @default.
- W4313067189 workType "article" @default.